CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation
暂无分享,去创建一个
T. Curiel | Chenghao Zhang | R. Svatek | Chen-ran Zhang | Niannian Ji | Yilun Deng | Neelam Mukherjee | Á. Padrón | C. Clark | Ryan M. Reyes | A. Padron | R. Reyes